Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
---|
05/18/2006 | US20060106216 Process for preparing the antiviral agent [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one |
05/18/2006 | US20060106215 epoxidation, hydrolysis; purification of entecavir using a brominated styrene based resin (Diaion", AMBERLITE"); use for treating hepatitis B viral infections |
05/18/2006 | US20060106214 3-isobutyl-8-(6-methoxy-isoquinolin-4-ylmethyl)-1-methyl-3, 7-dihydro-purine-2,6-dione; sexual dysfunction, premature labour, dysmenorrhoea, benign prostatic hyperplasia, bladder outlet obstruction, incontinence, (Prinzmetal) angina, hipotensive agent |
05/18/2006 | US20060106037 Purin-6-one-derivatives |
05/18/2006 | CA2585797A1 Lactam compounds and their use as pharmaceuticals |
05/17/2006 | EP1657243A1 Procedure for the production of amino alcohols |
05/17/2006 | EP1656378A2 Compounds and compositions as inhibitors of receptor tyrosine kinase activity |
05/17/2006 | EP1656370A2 Biaryl heterocyclic compounds and methods of making and using the same |
05/17/2006 | EP1423391B1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
05/17/2006 | CN1774635A Anti-epileptogenic agents |
05/16/2006 | US7045529 Imidazopyrimidinyl and imidazopyri dinyl derivatives |
05/16/2006 | US7045525 Use of (R)-peniciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases |
05/11/2006 | WO2006048427A1 Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines |
05/11/2006 | US20060100429 Alkynylpurine compounds and production methods thereof |
05/11/2006 | US20060100199 Novel condensed imidazole derivatives |
05/11/2006 | DE102004054054A1 Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine A process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines |
05/11/2006 | CA2586938A1 Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines |
05/10/2006 | EP1412354B1 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A 2a? RECEPTOR AND THEIR USE AS MEDICAMENTS |
05/10/2006 | EP1255764B1 Purine derivatives |
05/10/2006 | EP1016407B1 Xanthine derivatives for treating brain ischemia |
05/10/2006 | CN1771250A Xanthine derivatives as A2B adenosine receptor antagonists |
05/09/2006 | US7041824 Such as trans-N2-(4-aminocyclohexyl)-N6-(2-aminoethyl)-1H-purine-2,6-diamine trihydrochloride for treatment/prevention of fungal diseases |
05/09/2006 | US7041823 (Famciclovir); reacting the thallium salt of 2-aminopurine and 2-acetoxymethyl-4-bromobut-1-yl-acetate in a polar organic solvent under mild reaction conditions; selective coupling at the 9-position; by-product inhibition; antiviral drug |
05/09/2006 | US7041668 Substituted benzimidazole compounds and their use for the treatment of cancer |
05/09/2006 | CA2257646C Benzo[g]quinoline derivatives |
05/09/2006 | CA2233666C Heterocyclic fungicides |
05/04/2006 | WO2006046024A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
05/04/2006 | WO2006046023A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
05/04/2006 | WO2006045828A1 Hiv inhibiting bicyclic pyrimidine derivatives |
05/04/2006 | WO2006045565A1 Xanthine derivatives with hm74a receptor activity |
05/04/2006 | WO2006045564A1 Xanthine derivatives with hm74a receptor activity |
05/04/2006 | WO2006045552A1 Purine derivatives for use as adenosin a-2a receptor agonists |
05/04/2006 | WO2005112938A3 Disalt inhibitors of il-12 production |
05/04/2006 | US20060094870 Inosine derivatives and production methods therefor |
05/04/2006 | US20060094733 Purine derivatives as liver x receptor agonists |
05/04/2006 | US20060094701 Respiratory system disorders; antiinflamamtory agents; side effect reduction; administering terbutaline |
05/04/2006 | CA2730374A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
05/04/2006 | CA2584904A1 Xanthine derivatives with hm74a receptor activity |
05/04/2006 | CA2582434A1 Purine derivatives for use as adenosin a-2a receptor agonists |
05/04/2006 | CA2577588A1 Hiv inhibiting bicyclic pyrimidine derivatives |
05/03/2006 | EP1043021B1 Purine derivatives for the treatment of allergic diseases and systemic lupus erythematosus |
05/03/2006 | EP0810884B1 Treatment of vascular restenosis with inhaled nitric oxide |
05/02/2006 | US7037916 Antiinflammatory agents; antiarthritic agents; anticholesterol agents; cardiovascular disorders; muscle and skin disorders |
05/02/2006 | CA2198010C 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent |
04/27/2006 | WO2006044573A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
04/27/2006 | US20060089369 pyrimidine and pyridine derivatives; diabetes, neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency, cancer |
04/27/2006 | DE19741739B4 Supramolekulares Paarungssystem, dessen Herstellung und Verwendung Supramolecular mating system, its preparation and use |
04/27/2006 | CA2584209A1 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
04/26/2006 | EP1648895A1 Metabolite of xanthine phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction |
04/26/2006 | EP1648894A1 Method for the production of oh protected [4-(2.6-diamino-9h-purine-9-yl)- 1.3-dioxolane-2-yl]methanol derivatives |
04/26/2006 | EP1534708B1 Purine derivatives and their use as antiproliferative agents |
04/26/2006 | EP1379520B1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
04/26/2006 | EP1210348B9 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
04/26/2006 | CN1763040A Abacavir production method |
04/25/2006 | US7034152 Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta )]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one |
04/25/2006 | US7034016 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i]purin-5-one derivatives |
04/25/2006 | US7034014 Phosphonate compounds |
04/20/2006 | WO2006040558A1 Substituted adenines and the use thereof |
04/20/2006 | US20060084668 Isolated valacyclovir impurity, process for the preparation of valacyclovir impurity and use as a reference standard |
04/20/2006 | US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
04/20/2006 | US20060084651 Chemical compounds |
04/19/2006 | EP1647275A1 Solid pharmaceutical preparation |
04/19/2006 | EP1556140A4 Novel compounds |
04/19/2006 | EP1537112B1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
04/19/2006 | EP1253924B1 Nitrate salts of antimicrobial agents |
04/19/2006 | EP0901474B1 Aryl pyrimidine derivatives |
04/19/2006 | CN1252071C Xanthine Phosphodiesterase V inhibitors |
04/19/2006 | CN1251679C Nucleotide analog composition and synthesis method |
04/19/2006 | CN1251676C Phenyl xanthine derivative |
04/18/2006 | US7029835 Photothermographic element comprising improved base precursors and methods for their use |
04/13/2006 | US20060079541 e.g. 1-[(3-methyl-isoquinolin- 1 -yl)methyl]-3-methyl-7-(2-butyn- 1 -yl)-8-[(2-amino-ethyl) -methylamino]-xanthine; dipeptidyl-peptidase-IV (DPP-IV) inhibitor; antidiabetic, diuretic, antihypertensive agent; insulin resistance, obesity; irritable bowel syndrome (IBS), Crohn's disease, ulcerative colitis |
04/12/2006 | EP1644384A2 Process and intermediates for synthesis entecavir |
04/12/2006 | EP1644375A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
04/12/2006 | EP1554278B1 Xanthine derivatives, production thereof and use thereof as medicines |
04/12/2006 | EP1005356B1 Novel antibacterial agents |
04/12/2006 | CN1250548C Novel adenine derivatives |
04/12/2006 | CN1250224C Theobromine with anticancer activity |
04/11/2006 | US7026310 Heteroaryl derivatives and their use as medicaments |
04/06/2006 | WO2005113554A3 Method of preparing 3-phenyl-2-[9h-purin-6-ylamino)-methyl]-3h-quinazolin-4-one and substituted and related compounds |
04/06/2006 | US20060074095 Novel purine derivatives, preparation method and use as medicines |
04/06/2006 | US20060074056 Inhibitors of VEGF receptor and HGF receptor signaling |
04/05/2006 | EP1244668B1 Purine derivatives, process for their preparation and use thereof |
04/05/2006 | EP1244667B1 Cyclohexene nucleic acids |
04/05/2006 | CN1249051C Muscarinic agonists |
04/04/2006 | US7022851 A peptide nucleic acid derivatives comprising a N-acetyl-1-(2-nitro-phenensulfonyl)-peperazin-2-one core group; oligomerization, for specific binding to DNA as well as RNA, stability |
04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
03/30/2006 | WO2006033703A1 Imidazo[4,5-d]pyrimidines, their uses and methods of preparation |
03/30/2006 | WO2005019211A3 Biaryl heterocyclic compounds and methods of making and using the same |
03/30/2006 | US20060069108 Use of (R)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases |
03/30/2006 | DE102004046530A1 New bicyclic imidazole derivatives are dipeptidylpeptidase-IV inhibitors useful to treat e.g. arthritis, obesity, allograft transplantation and calcitonin-induced osteoporosis |
03/30/2006 | DE102004043944A1 Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel New 8- (3-amino-piperidin-1-yl) -xanthines -7- (but-2-ynyl), their preparation and their use as medicaments |
03/30/2006 | CA2580725A1 Novel heterocyclic nf-kb inhibitors |
03/30/2006 | CA2574220A1 Imidazo[4,5-d]pyrimidines, their uses and methods of preparation |